Mechanisms of DNA damage induced emphysema

DNA损伤诱发肺气肿的机制

基本信息

  • 批准号:
    10431937
  • 负责人:
  • 金额:
    $ 62.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-07-15 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

Abstract This renewal application aims to understand the genetic determinants of emphysema susceptibility. Emphysema-chronic obstructive disease (COPD) affect at least 10 million individuals in the United States and are a major cause of mortality and disability around the world. Among smokers, only 10-15% COPD and genetic factors are known to contribute to this susceptibility. In the prior funding period, we identified mutant telomerase genes as a second Mendelian cause of familial and early-onset emphysema beyond alpha-1 antitrypsin deficiency. We documented a specific predilection in female smokers who comprised 90% of mutant telomerase-associated emphysema. In animal models, we identified alveolar stem cell senescence as a driver of alveolar destruction and inflammation. For this renewal application, we focus on understanding how genetic defects in DNA damage, beyond telomere dysfunction, contribute to emphysema biology and susceptibility. We have identified a new animal model in which females exposed to genotoxic damage develop lung disease but not males. For the proposed experiments, we will prospectively examine male-female differences in cigarette smoke susceptibility and define the contribution of defective DNA repair as a risk factor for human emphysema. The focus on sex differences in our proposal is particularly timely since there is evidence that elsewhere, and this phenomenon is expected to grow since cigarette smoke rates remain on the rise in women. The proposed therefore have the potential to fill gaps in understanding emphysema biology and susceptibility and to shed light on sex-specific differences of emphysema penetrance in a context of significant
摘要 这个更新申请的目的是了解肺气肿易感性的遗传决定因素。 在美国,肺气肿-慢性阻塞性疾病(COPD)影响至少1000万个体, 是全世界死亡和残疾的主要原因。在吸烟者中,只有10-15%的COPD和 已知遗传因素有助于这种易感性。在上一个融资期,我们发现了突变体, 端粒酶基因是α-1以外家族性早发性肺气肿的第二个孟德尔病因 抗胰蛋白酶缺乏症我们记录了女性吸烟者的一种特殊偏好, 端粒酶相关性肺气肿在动物模型中,我们确定肺泡干细胞衰老是一个驱动因素, 肺泡的破坏和炎症。对于这个更新应用程序,我们专注于了解基因如何 DNA损伤的缺陷,除了端粒功能障碍之外,还导致肺气肿生物学和易感性。我们 已经确定了一种新的动物模型,在这种模型中,暴露于遗传毒性损伤的雌性动物会患上肺病, 而不是男性。对于所提议的实验,我们将前瞻性地检查男性和女性在吸烟方面的差异。 吸烟易感性和定义的贡献有缺陷的DNA修复作为一个危险因素, 肺气肿我们的提案中对性别差异的关注特别及时,因为有证据表明, 在其他地方,这种现象预计会增加,因为吸烟率仍在上升, 妇女因此,所提出的有可能填补理解肺气肿生物学的空白, 易感性,并揭示了性别特异性差异的肺气肿发病率的背景下,

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mary Y Armanios其他文献

Mary Y Armanios的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mary Y Armanios', 18)}}的其他基金

Cancer Genetics of Short Telomere Syndromes
短端粒综合征的癌症遗传学
  • 批准号:
    10434717
  • 财政年份:
    2018
  • 资助金额:
    $ 62.71万
  • 项目类别:
Cancer Genetics of Short Telomere Syndromes
短端粒综合征的癌症遗传学
  • 批准号:
    10199960
  • 财政年份:
    2018
  • 资助金额:
    $ 62.71万
  • 项目类别:
Mechanisms of Telomere-Induced Emphysema
端粒诱发肺气肿的机制
  • 批准号:
    8894574
  • 财政年份:
    2014
  • 资助金额:
    $ 62.71万
  • 项目类别:
Mechanisms of DNA damage induced emphysema
DNA损伤诱发肺气肿的机制
  • 批准号:
    10187637
  • 财政年份:
    2014
  • 资助金额:
    $ 62.71万
  • 项目类别:
Mechanisms of Telomere-Induced Emphysema
端粒诱发肺气肿的机制
  • 批准号:
    8762045
  • 财政年份:
    2014
  • 资助金额:
    $ 62.71万
  • 项目类别:
Mechanisms of Telomere-Induced Emphysema
端粒诱发肺气肿的机制
  • 批准号:
    9258486
  • 财政年份:
    2014
  • 资助金额:
    $ 62.71万
  • 项目类别:
Mechanisms of DNA damage induced emphysema
DNA损伤诱发肺气肿的机制
  • 批准号:
    10636855
  • 财政年份:
    2014
  • 资助金额:
    $ 62.71万
  • 项目类别:
Mechanisms of DNA damage induced emphysema
DNA损伤诱发肺气肿的机制
  • 批准号:
    9917077
  • 财政年份:
    2014
  • 资助金额:
    $ 62.71万
  • 项目类别:
The Role of Telomere Shortening in MDS-AML Pathogenesis (resubmission)
端粒缩短在 MDS-AML 发病机制中的作用(重新提交)
  • 批准号:
    8246709
  • 财政年份:
    2012
  • 资助金额:
    $ 62.71万
  • 项目类别:
The Role of Telomere Shortening in MDS-AML Pathogenesis (resubmission)
端粒缩短在 MDS-AML 发病机制中的作用(重新提交)
  • 批准号:
    8435373
  • 财政年份:
    2012
  • 资助金额:
    $ 62.71万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 62.71万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 62.71万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 62.71万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 62.71万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 62.71万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 62.71万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 62.71万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 62.71万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 62.71万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 62.71万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了